This study evaluates the non-specific effects on child mortality and morbidity of a second dose of measles in the second year of life. Half of the study participants will receive a second dose of measles vaccine at 18 months of age while the other half will receive a second dose of measles by 4 years of age or at the end of the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
3,812
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau
Mortality
Mortality registered monthly by Health and Demographic Surveillance System fieldworkers. Mortality will be combined with hospital admissions in the analysis to form the outcome severe morbidity. This will be examined overall and by sex
Time frame: 30 months
Hospital admissions
Hospital admissions registered daily at the national hospital. Hospital admissions will be combined with mortality in the analysis to form the outcome severe morbidity. This will be examined overall and by sex
Time frame: 30 months
Hospital admission by cause
Causes of hospital admissions registered daily at the national hospital. These will be examined overall and by sex
Time frame: 30 months
Consultations
Consultations registered daily at the local health centers and the national hospital. These will be examined overall and by sex
Time frame: 30 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.